Phase
Condition
Musculoskeletal Diseases
Rheumatoid Arthritis
Joint Injuries
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Rheumatoid arthritis of at least 2 years duration
On at least third biologic with a different mechanism of action for at least 12 weeks
Active disease as defined by at least 6 tender and 6 swollen joints
Erythrocyte sedimentation rate (ESR) at least 28 mm/hr or C-reactive protein (CRP) atleast 1.2 times the upper limit of normal
Stable dose of disease modifying anti-rheumatic drug (DMARD) and prednisone for atleast 4 weeks
Exclusion
Exclusion Criteria:
Prior treatment with Acthar Gel
History of intolerance or allergy to glucocorticoids
Unstable diabetes
Active infection
Study Design
Study Description
Connect with a study center
Arthritis Treatment Center
Frederick, Maryland 21702
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.